PRELUDE CAPITAL MANAGEMENT, LLC - CADENCE PHARMACEUTICALS INC ownership

CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 3 filers reported holding CADENCE PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 1.7%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CADENCE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2013$34,0003,8000.01%
Other shareholders

There were no reported owners of CADENCE PHARMACEUTICALS INC in Q1 2014.

NameSharesValueWeighting ↓
View complete list of CADENCE PHARMACEUTICALS INC shareholders